Research Topics
| Clive R SeedSummaryAffiliation: Australian Red Cross Blood Service Country: Australia Publications
|
Detail Information
Publications
Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NATClive R Seed
Australian Red Cross Blood Service, 290 Wellington Street, Perth, Western Australia 6000
Transfusion 42:1365-72. 2002..The primary objective of this paper is to assess the accuracy of three published models in predicting the impact of implementing HIV and HCV NAT in Australia...
Relapsing vivax malaria despite chemoprophylaxis in two blood donors who had travelled to Papua New GuineaClive R Seed
Australian Red Cross Blood Service, Perth, WA, Australia
Med J Aust 192:471-3. 2010..vivax in donors returning from malaria-endemic countries, as well as the inability to identify the potential for relapse using current malarial screening tests...
Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malariaC R Seed
Australian Red Cross Blood Service, Perth, WA, Australia
Vox Sang 98:e182-92. 2010..This report assesses the safety and efficacy of the strategy since inception...
The risk of dengue transmission by blood during a 2004 outbreak in Cairns, AustraliaClive R Seed
Australian Red Cross Blood Service, University of Western Australia, 69 Walters Drive, Osborne Park, WA 6017, Australia
Transfusion 49:1482-7. 2009..The purpose of this study was to assess the risk of transfusion-transmitted DENV during a 2004 outbreak in the Australian city of Cairns...
Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative bloodClive R Seed
Australian Red Cross Blood Service, School of Surgery, University of Western Australia, Perth, Australia
Transfusion 49:134-45. 2009..However, since in the majority of cases both CMV IgG and IgM are detected concomitantly during early seroconversion, CMV assays based only on IgG are now widely applied for donor screening...
No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with menClive R Seed
Australian Red Cross Blood Service, Perth
Transfusion 50:2722-30. 2010..This retrospective analysis assesses the impact on HIV prevalence of implementing an abridged 12-month deferral for male-to-male sex...
Evidence for undetected malaria infection in non-immune Australian travellers not taking chemoprophylaxisClive R Seed
Australian Red Cross Blood Service, 97 Great Eastern Highway Rivervale, Western Australia 6103, Australia
Acta Trop 99:62-6. 2006..These data underscore the value of effective antimalarial prophylaxis in non-immune travellers visiting high malaria-risk areas but also suggest that unrecognised infections can occur in those unprotected by chemoprophylaxis...
Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virusC R Seed
Australian Red Cross Blood Service, Perth, Western Australia, Australia
Intern Med J 35:592-8. 2005..Using several refinements to the original methodology, as well as an additional 2 years of data, new risk estimates have been derived...
The current status and potential role of laboratory testing to prevent transfusion-transmitted malariaClive R Seed
Australian Red Cross Blood Service, Perth, Australia
Transfus Med Rev 19:229-40. 2005..Assuming that they are successfully marketed, their high cost may also impact their cost-effectiveness in comparison with targeted malaria testing strategies already in place in some jurisdictions...
The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malariaC R Seed
Australian Red Cross Blood Service, Perth, Australia
Vox Sang 88:98-106. 2005....
Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassaysClive R Seed
Australian Red Cross Blood Service, Perth, Western Australia, Australia
Transfusion 43:226-34. 2003..However, such strategies can generate nonspecific in determinate results. The aim of this report is to present the results of an alternative strategy based on the use of sequential immunoassays (SI) before immunoblot testing...
Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategiesL Mison
Australian Red Cross Blood Service, Brisbane, Australia Australian Red Cross Blood Service, Perth, Australia
Vox Sang 84:11-9. 2003..The performance data for ID testing in particular should serve as a useful benchmark for evaluating candidate NAT systems that are fully automated...
Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNAAngelo R Margaritis
Australian Red Cross Blood Service Enterprise, 97 Great Eastern Highway, Rivervale, Western Australia 6103
Transfusion 47:1783-93. 2007..This study compared the performance of two "multiplex" NAT assays and their automated testing platforms...
Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification testsC Hyland
Australian Red Cross Blood Service, Brisbane, QLD, Australia
Vox Sang 85:1-8. 2003....
Emerging viral threats to the Australian blood supplyRobert A Dunstan
School of Biomedical Sciences, the Western Australian Biomedical Research Institute, Curtin University, Perth, WA
Aust N Z J Public Health 32:354-60. 2008..To assess the risk to the Australian blood supply posed by emerging or re-emerging viral infections...
Can blood tranfusion transmit cancer? A literature reviewHung Yang
Australian Red Cross Blood Service, Sydney HY and Perth JL, CRS and AJK, Australia
Transfus Med Rev 24:235-43. 2010....
Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004Guifang Shang
Blood and Tissue Unit, Therapeutic Goods Administration, Woden ACT, Australia
Transfusion 47:529-39. 2007..Such estimates are an essential prerequisite to monitoring and improving transfusion safety as well as supporting evidence based assessment of the value of implementing new screening interventions...
